Key Highlights

  • Price $326.58 (-5.6% today) · Mkt cap $432.8 billion · TD Cowen raises LRCX price target 18% to $400 · Next catalyst: earnings season
  • Shares have surged 76.5% year-to-date but fallen 11.0% over the past month
  • Analysts point to leading-edge logic and memory chip ramp-ups as key demand drivers

Lam Research (NASDAQ: LRCX) received a sharp upgrade to its price target as two major firms raised their outlook on the semiconductor equipment maker. TD Cowen analyst Krish Sankar lifted his target by 18%, from $340 to $400, while maintaining a Buy rating on the stock. The move comes as the company prepares for earnings season, with analysts betting on sustained demand for advanced chipmaking tools.

The Call

TD Cowen’s revised target reflects an 18% increase, pushing the stock’s potential upside to new highs. Mizuho followed suit, raising its price target on Lam Research from $380 to $400 and keeping its Outperform rating. Both firms acted on July 9, signaling confidence in the company’s positioning ahead of key financial disclosures.

The adjustments mark a rare alignment between two major analysts on the stock’s valuation.

The Thesis

The bullish outlook hinges on AI-driven demand for leading-edge semiconductor manufacturing. The firm also raised targets across the broader semiconductor equipment sector, citing AI’s role in expanding foundry, logic, and DRAM capacity. Lam Research, a critical player in chip fabrication, stands to benefit as manufacturers scale production to meet surging AI workloads.

Market Reaction

Shares of Lam Research fell 5.6% to $326.58 in recent trading, paring some of its year-to-date gains. The stock has climbed 76.5% since January but dropped 11.0% over the past month, reflecting broader volatility in the semiconductor space. With a market capitalization of $432.8 billion, the company remains a bellwether for chip equipment demand.

Investors are now watching for earnings reports to validate the analysts’ optimistic projections. Based on analyst actions reported July 9.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.